Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brijker, F.
Right arrow Articles by Folgering, H. Th. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brijker, F.
Right arrow Articles by Folgering, H. Th. M.
(Chest. 2001;119:1820-1826.)
© 2001 American College of Chest Physicians

Underestimation of Nocturnal Hypoxemia Due to Monitoring Conditions in Patients With COPD*

Folkert Brijker, MD; Frank J. J. van den Elshout, MD, PhD; Yvonne F. Heijdra, MD, PhD and Hans Th. M. Folgering, MD, PhD

* From the Department of Pulmonology (Drs. Brijker and van den Elshout), Rijnstate Hospital, Arnhem, The Netherlands; and the Department of Pulmonology (Drs. Heijdra and Folgering), Dekkerswald, University of Nijmegen, The Netherlands.

Correspondence to: Folkert Brijker, MD, Department of Pulmonary Diseases, Rijnstate Hospital, PO Box 9555, 6800 TA Arnhem, The Netherlands; e-mail: zonnebloem{at}compuserve.com

Study objectives: COPD patients run a risk of developing nocturnal oxygen desaturation. When evaluating patients with nocturnal hypoxemia, an unfamiliar hospital environment and the monitoring equipment may cause sleep disturbances. It was hypothesized that increased sleep disruption will lead to fewer instances of desaturation during a night of monitoring.

Design:The following forms of monitoring were evaluated prospectively on 3 nights for each patient: oximetry at home; polysomnography (PSG) at home; and PSG in the hospital.

Setting: Department of Pulmonology, Rijnstate Hospital Arnhem, The Netherlands.

Patients: Fourteen stable COPD patients (7 men; median age, 71.5 years; age range, 59 to 81 years; FEV1, 32.5% predicted; FEV1 range, 19 to 70% predicted) participated in the study. All subjects had significant instances of nocturnal arterial oxygen desaturation. Those patients with a sleep-related breathing disorder or cardiac failure were excluded from the study.

Measurements and results: The mean nocturnal arterial oxygen saturation (SaO2) level was higher during PSG monitoring at home (89.7%; range, 77 to 93%) than during oximetry monitoring (88.5%; range, 80 to 92%) [p < 0.025]. The fraction of time spent in hypoxemia (ie, SaO2 < 90%) was lower during PSG monitoring at home (40.8%; range, 5 to 100%) than during oximetry monitoring (59.9%; range, 6 to 100%) [p < 0.01]. Desaturation time ({Delta}SaO2 > 4%) was lower during PSG monitoring at home (22.1%; range, 3 to 63%) during PSG monitoring at home than during oximetry monitoring (50.4%; range, 4 to 91%) [p < 0.01]. A correction for actual sleep during PSG monitoring reduced the differences between PSG monitoring at home and oximetry monitoring, although a difference in the desaturation time remained (PSG monitoring at home, 31.9% [range, 2 to 75%]; oximetry monitoring, 50.4% [range, 4 to 91%]) [p = 0.041]. A comparison of sleep architectures for nights when PSG was being monitored showed a higher arousal index in the hospital than at home (PSG monitoring in the hospital, 5.6 arousals per hour [range, 2 to 16 arousals per hour]; PSG monitoring at home, 2.5 arousals per hour [range, 1 to 6 arousals per hour]) [p < 0.025], but no differences in SaO2 levels were found between PSG monitoring at home and PSG monitoring in the hospital.

Conclusion: The artifacts due to sleep-monitoring equipment may cause an underestimation of the degree of nocturnal hypoxemia in COPD patients. The addition of an unfamiliar environment causes more sleep disruption, but this does not affect nocturnal SaO2 levels further.

Key Words: COPD • nocturnal hypoxemia • oximetry • polysomnography




This article has been cited by other articles:


Home page
ChestHome page
C. A. Lewis, T. E. Eaton, W. Fergusson, K. F. Whyte, J. E. Garrett, and J. Kolbe
Home Overnight Pulse Oximetry in Patients With COPD: More Than One Recording May Be Needed
Chest, April 1, 2003; 123(4): 1127 - 1133.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American College of Chest Physicians.